Recent Press Releases

Update on Novartis influenza vaccines acquisition

CSL Limited (ASX:CSL; USOTC: CSLLY) today announced that it has secured the necessary approvals required to proceed with the acquisition of the influenza vaccines business of Novartis and that it is...

Novavax Announces Positive Data from Phase 2 Trial of Quadrivalent Seasonal Influenza VLP

Gaithersburg, MD, July 30, 2015 -- Novavax, Inc. (Nasdaq: NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and...

VALNEVA and PaxVax Enter into Marketing and Distribution Agreement

LYON, France, July 23, 2015 (GLOBE NEWSWIRE) -- Valneva SE ("Valneva"), a leading pure-play vaccine biotech company and PaxVax, Inc. ("PaxVax"), a fully integrated specialty...

TSRI Researcher Wins $4.5 Million in Grants to Support Development of AIDS Vaccine

Newswise — LA JOLLA, CA – July 23, 2015 – The Scripps Research Institute (TSRI) has been awarded two grants from the Bill & Melinda Gates Foundation totaling more than $4.5...

Vaxin First-in-Man Phase I Clinical Trial Initiated in Chronically Infected Hepatitis B Patients

GAITHERSBURG, MD, USA I July 27, 2015 I Vaxin Inc., a clinical stage vaccine and immunotherapeutics company, today announced that it has enrolled the first patient into a phase I clinical trial of...

NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES NEW ANALYSES CONFIRMING THAT SANOFI PASTEUR'S VACCINE CANDIDATE SAFELY PROTECTS PRE-ADOLESCENTS TO ADULTS AGAINST DENGUE

- The highest burden of dengue disease globally in endemic countries is in pre-adolescent to adults age group1,2,3 - o In a new pooled analysis, dengue vaccine candidate protected two out of three...

PFIZER REPORTS SECOND-QUARTER 2015 RESULTS

Second-Quarter 2015 Reported Revenues(1) of $11.9 Billion Second-Quarter 2015 Adjusted Diluted EPS(2) of $0.56, Reported Diluted EPS(1) of $0.42 Raised Midpoints of 2015 Financial Guidance(3)...

Bavarian Nordic Announces Initiation of NCI-sponsored Phase 2 Study of PROSTVAC in Patients with Localized Prostate Cancer

COPENHAGEN, Denmark - July 24, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the first patient has been enrolled in a new phase 2 clinical study of PROSTVAC, the...

GSK's malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa

24 July 2015 Issued: London, UK WHO will now assess how the world's first malaria candidate vaccine might be used alongside other tools to prevent malaria GSK announced today that the Committee...

First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions The European Medicines Agency's Committee for Medicinal Products for Human Use...

PATH Malaria Vaccine Initiative welcomes positive opinion by European regulators on GSK's Mosquirix™ (RTS,S)

Decision paves the way for World Health Organization to assess how a malaria vaccine might be used in young children in sub-Saharan Africa Innovative partnership supported scientific achievement...

Virus-Like Particle Vaccine Protects Mice from Many Flu Strains

NIAID Research Could Aid Development of Universal Flu Vaccine ​ WHAT: A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public...

Novavax Announces Positive Top-Line Data From Phase 1 Ebola Vaccine Trial on WHO Teleconference

GAITHERSBURG, Md., July 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...

Emory University immunologists identify long-lived antibody-producing cells in bone marrow

Immunologists from Emory University have identified a distinct set of long-lived antibody-producing cells in the human bone marrow that function as an immune archive. The cells keep a catalog of how...

bioCSL Inc. Begins Shipping AFLURIA for the 2015-2016 US Seasonal Influenza Campaign

KING OF PRUSSIA, Pa., July 13, 2015 /PRNewswire/ -- bioCSL Inc. announced today it has begun shipping AFLURIA, Influenza Vaccine in advance of the 2015-2016 influenza season. In support of improving...

Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in United States

Leading influenza vaccine manufacturer to distribute more than 65 million doses to help protect people six months and older against the flu -- Direct shipments to health care providers and...

GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed

PHILADELPHIA, July 16, 2015 /PRNewswire/ -- GSK (LSE/NYSE: GSK) announced today it has begun shipping FLUARIX® QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, following...

VUMC becomes Human Vaccines Project's first scientific hub

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) are pleased to announce that VUMC has become the Project's first...

Bavarian Nordic Announces that the Oxford Vaccines Group has Initiated a Phase 2 Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN® Filo and Janssen's AdVac® Technology

COPENHAGEN, Denmark, July 15, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Oxford Vaccines Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine...

EMA to further clarify safety profile of human papillomavirus (HPV) vaccines

EMA to further clarify safety profile of human papillomavirus (HPV) vaccines 13/07/2015 The European Medicines Agency (EMA) has started a review of HPV vaccines to further clarify aspects of their...